10,349
Views
29
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Detection of recurrence in early stage endometrial cancer – the role of symptoms and routine follow-up

, , , , &
Pages 262-269 | Received 15 Aug 2016, Accepted 21 Nov 2016, Published online: 12 Jan 2017
 

Abstract

Background: Considerable controversy remains as to the optimal organization of endometrial cancer follow-up.

Aim: To evaluate the relationship between the way recurrence was detected and survival after treatment for endometrial cancer. Further, to identify characteristics associated with a pre-scheduled examination in women with symptomatic recurrence.

Material and methods: All women with early stage endometrial cancer during 2005–2009 were included in a population-based historical cohort derived from the Danish Gynecological Cancer Database. Women diagnosed with recurrence within three years after primary surgery and the mode of recurrence detection were identified from hospital charts: asymptomatic recurrence detected at regular follow-up, symptomatic recurrence detected at regular follow-up or symptomatic recurrence detected in between follow-up. Survival of women with symptomatic and asymptomatic disease was compared. Furthermore, characteristics associated with self-referral as compared to presenting symptoms at regular follow-ups were identified using univariate analyses.

Results: In total, 183 cases of recurrence (7%) were identified in the cohort of 2612 women. Of these, 65.5% were symptomatic with vaginal bleeding as the most prevalent symptom. Asymptomatic women had a significantly better three-year survival rate compared to symptomatic women (80.3% vs. 54.3%, p < 0.01). A total of 2.3% of the entire population had an asymptomatic recurrence. Women diagnosed at a pre-scheduled visit due to symptoms had a higher educational level (p = 0.03) and more often high-risk disease (p = 0.02) than symptomatic women diagnosed at regular follow-up.

Conclusion: Early stage endometrial cancer carries a low risk of recurrence. Survival appears to be superior in asymptomatic patients, but length-time bias, i.e. the effect of aggressive tumor biology in symptomatic recurrences, may bias results in non-randomized controlled trials. Well educated patients with symptoms of recurrence more often sought medical attendance compared to less educated counterparts. This should be considered if patient-initiated follow-up is the standard care.

Acknowledgments

We thank the Danish Gynaecological Cancer Group for providing us with clinical data from their database.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The research for this paper was financially supported by the Danish Cancer Society [grant no. R94-A5679 Rp7423], the University of Southern Denmark, the Region of Southern Denmark [grant no. 13/6697], and Odense University Hospital [grant no. 12/26914].The National Research Center of Cancer Rehabilitation at the Research Unit of General Practice, University of Southern Denmark, is partly funded by the Danish Cancer Society.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.